New drug duo takes on Hard-to-Treat leukemia
Disease control
Recruiting now
This study tests whether combining two targeted drugs, pirtobrutinib and venetoclax, can eliminate cancer cells in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whose disease got worse despite taking standard BTK inhibitors. About 30 adults wh…
Phase: PHASE2 • Sponsor: Kerry Rogers • Aim: Disease control
Last updated May 15, 2026 11:53 UTC